News > Latest News

Walk News | Sponsor & Foundation News | News in the Parkinson's Disease Community

Walk News

Click on a headline to read the latest about Parkinson's Unity Walk. 

2019 Parkinson’s Unity Walk Raises Over $1.5 Million in Donations; Now Funding Research 

The 25th Annual Parkinson’s Unity Walk Raised Over $1.5 Million for Parkinson’s Disease Research

Top 50 Teams - Parkinson's Unity Walk 2019

Submit Your Favorite Walk Moments from the 2019 Parkinson's Unity Walk

Parkinson's Unity Walk 2019 Memory Quilt

Fox Rehabilitation Parkinson’s Research Fair

Team Week 2019 - and the Winners Are ...

It's Team Week! March 25th - 29th

The 25th Parkinson’s Unity Walk to Be Held on Saturday, April 27th in New York City’s Central Park

Over $1.5 Million in Donations Raised by the 2018 Parkinson's Unity Walk Now Funding Research

The Parkinson Alliance Announces Debbie Ayers as Event Manager for the Parkinson’s Unity Walk

The 24th Annual Parkinson’s Unity Walk Raised Over $1.5 Million for Parkinson’s Disease Research

Top 50 Teams - Parkinson's Unity Walk 2018

2018 PUW Favorite Walk Moments

Come Connect with Others at Sunovion’s Parkinson’s Educational Breakfast Program Before the Unity Walk!

ATTENTION Returning Team Captains: Important News About Your 2018 Team Page

The Parkinson's Unity Walk mourns the loss of Dr. Robert Burke

Parkinson's Unity Walk Elects New Board Member; Announces New Roles for Two Board Members

The Parkinson's Unity Walk mourns the loss of Lupe McCann

2018 Light of Day Winterfest Will Kick Off Fundraising in NJ

The 23rd Parkinson’s Unity Walk Raised Over $1.5 Million in Donations for Parkinson’s Disease Research

Top 50 Teams - Parkinson's Unity Walk 2017

Letter on Health Care Reform to President-Elect Trump from Patient Advocacy Organizations

Your Dollars at Work – 2016 PUW Research Grants Have Been Awarded

Attendees at the 22nd Parkinson’s Unity Walk Will Find Valuable New Resources for Managing Symptoms of Parkinson’s Disease

back to top

Sponsor & Foundation News

Sunovion Announces FDA Filing Acceptance of Resubmitted New Drug Application for Apomorphine Sublingual Film

NYC Area: Free LSVT-LOUD Educational Seminar on August 16

Kyowa Kirin Announces FDA Reviewing New Drug Application for Istradefylline

Acorda Therapeutics announces Inbrija Approved in US to Treat Off Periods in Parkinson’s Patients on Carbidopa/Levodopa

“Milestone Moment” as LRRK2 inhibitor enters human testing

The Parkinson Alliance Presented Patient-Centered Research on Vision and Parkinson’s Disease at American Congress of Rehabilitation Medicine in Dallas, Texas

Adamas Pharmaceuticals Launches “Dyskinesia Is A Jerk™,” a Campaign to Raise Awareness and Highlight the Impact of Parkinson’s Disease Dyskinesia

Parkinson's Foundation Designates Three Centers of Excellence in Parkinson's Care

Sunovion Presents Data from Pivotal Phase 3 Study of Apomorphine Sublingual Film (APL-130277)

Adamas Presents New Data Analysis Demonstrating that GOCOVRI™ Reduces Transitions between Dyskinesia and OFF Episodes Throughout the Day

Medtronic Launches New Clinician Programmer for Deep Brain Stimulation Therapy

Sunovion Announces FDA Acceptance of New Drug Application for Apomorphine Sublingual Film (APL-130277)

Acorda Announces EMA Validation of the MAA Submission for INBRIJA™

Introducing Little Big Things™ from Sunovion Pharmaceuticals Inc.

Adamas Announces Multiple Data Presentations at the American Academy of Neurology Annual Meeting

Sunovion Submits New Drug Application to the FDA for Apomorphine Sublingual Film for the Treatment of OFF Episodes Associated with PD

Adamas Announces Publication of Data Supporting the Benefits of GOCOVRI™ in Parkinson’s Disease Patients with Dyskinesia

Lundbeck to acquire Prexton Therapeutics

Acorda Launches New Initiative - “Live Well. Do Tell.™” to Support People with Parkinson’s

Nuplazid and Clozaril Are Most Reliable Parkinson’s Psychosis Therapies, Review Finds

Acorda Announces FDA Acceptance of New Drug Application for INBRIJA™

Adamas Announces Publication of Amantadine Immediate Release Subgroup Analysis from EASE LID 2 Open-label Study

Acorda Therapeutics Announces FDA Approval of INBRIJA™ (levodopa inhalation powder) (December 21, 2018)

back to top

News in the Parkinson's Disease Community

Attend the 3rd Parkinson’s IQ + You Event on January 11th, 2020 in Phoenix, AZ

Join 2nd Parkinson’s IQ + You Event on December 14th, 2019 in Anaheim, CA

FREE Program-Be Stronger, Live Longer with Parkinson’s Disease-Teaneck, NJ

Join the Parkinson’s Unity Walk at Parkinson’s IQ + You on September 14, 2019, in Atlanta, GA

In 2019 and 2020, The Michael J. Fox Foundation and Acadia Pharmaceuticals Will Host a Series of Local Educational Events for Patients and Their Care Partners Around the Country

Sinemet CR Discontinued; Learn More About Options

Results of New Study on the Economic Burden of Parkinson’s Disease Finds That the Total Yearly Cost Is $52 Billion on Patients, Families, and the Federal Government, Doubling Previous Estimates

Dance for Parkinson’s - NJ Spring Sessions FREE!

Findings on Using Azilect (Rasagiline) as an Add-On Therapy

Axovant Announced Administration of AXO-Lenti-PD, A Novel Gene Therapy for Patient’s with Parkinson’s Disease, to First Patient in Clinical Study

NYC Area: Free LSVT-LOUD Educational Seminar on November 30

NYC Area: Free LSVT-LOUD Educational Seminar on December 1

Life with Parkinson’s, Essential Tremor or Dystonia?

Method Developed to Test New Parkinson's Therapies

New Hope for Parkinson’s Disease Cure as Treatment Enters Human Trials

Princeton Ballet School Introduces New Dance Class for People with Parkinson's Disease

Johns Hopkins Startup Neuraly Plans Phase 1 Parkinson’s Trial

UA Clinical Trial to Repurpose Ketamine for Parkinson's Patients

Computer Model to Select Parkinson’s Patients Who Benefit Most from Deep Brain Stimulation

Experimental Drug Stops Parkinson's Disease Progression in Mice

Parkinson's Disease May Soon Be Treated with Blood Pressure Drug

FDA Grants RMAT Designation for VY-AADC for Parkinson's Disease

A Clinical Trial of Nilotnib in People Living with Parkinson’s Disease

The Apple Watch Will Monitor Symptoms of Parkinson's Disease

Deep Brain Stimulation Device That Can Self-Tune Shows Promise in Small Parkinson’s Study

Phase 1 Trial Finds Potential Parkinson’s Vaccine, Affitope PD01A, to be Safe and Possibly Effective

Scientists Just Found an Unexpected Link Between Tuberculosis and Parkinson's Disease

FDA Continues Crack Down on Unapproved Stem Cell Clinics

back to top